The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase I study of combination of crizotinib (C) and dasatinib (D) in patients (pts) with advanced cancer.
 
Shumei Kato
No Relationships to Disclose
 
Denis Leonardo Fontes Jardim
Consulting or Advisory Role - Janssen
Speakers' Bureau - GlaxoSmithKline; Pfizer
 
Faye M. Johnson
Leadership - Spring Creeck Urology (I)
Research Funding - PIQUR
 
Vivek Subbiah
No Relationships to Disclose
 
Sarina Anne Piha-Paul
Research Funding - Biomarin; GlaxoSmithKline; Helix BioPharma; Merck; Novartis; Puma Biotechnology
 
Apostolia Maria Tsimberidou
Research Funding - Baxter (Inst); Celgene (Inst); EMD Serono (Inst); Foundation Medicine (Inst); NCCN (Inst)
 
Gerald Steven Falchook
Employment - HealthONE; Sarah Cannon Research Institute
Research Funding - ARMO BioSciences; AstraZeneca; Celgene; EMD Serono; Genmab; GlaxoSmithKline; Incyte; Kolltan Pharmaceuticals; MedImmune; Millennium; Novartis; Vegenics
Patents, Royalties, Other Intellectual Property - Handbook of Targeted Cancer Therapy
Travel, Accommodations, Expenses - EMD Serono; Millennium; Sarah Cannon Research Institute
 
Daniel D. Karp
No Relationships to Disclose
 
Jennifer J. Wheler
No Relationships to Disclose
 
Ralph Zinner
No Relationships to Disclose
 
Filip Janku
No Relationships to Disclose
 
Siqing Fu
No Relationships to Disclose
 
Lakshmi Dandu
No Relationships to Disclose
 
Elsa Browne
No Relationships to Disclose
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche; Sysmex
Consulting or Advisory Role - Genentech; Novartis; Roche
Research Funding - AstraZeneca; Bayer; Calithera Biosciences; Debiopharm Group; Genentech; Novartis; Taiho Pharmaceutical
 
David S. Hong
No Relationships to Disclose